Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Eiger BioPharmaceuticals (EIGR) News Today

Eiger BioPharmaceuticals logo

EIGR Latest News

Remembering John Harlin, Eiger Legend
Eiger Biopharmaceuticals Inc (EIGRQ)
Massive Rockfall on the North Face of the Eiger
Eiger BioPharmaceuticals, Inc. (EIGRQ)
72C.SG,0P00015QPW,0 (72C.SG)
Requiem for Eiger Biopharmaceuticals
Eiger BioPharmaceuticals (Nasdaq:EIGR) Headline
Trading was temporarily halted for "EIGR" at 12:04 PM with a stated reason of "LULD pause."...
Eiger BioPharmaceuticals (Nasdaq:EIGR) Headline
Trading was temporarily halted for "EIGR" at 11:04 AM with a stated reason of "LULD pause." Trading set to resume at 12:04 PM.
Eiger BioPharmaceuticals (Nasdaq:EIGR) Headline
Trading was temporarily halted for "EIGR" at 12:04 PM with a stated reason of "LULD pause."...
Eiger BioPharmaceuticals (Nasdaq:EIGR) Headline
Trading was temporarily halted for "EIGR" at 11:04 AM with a stated reason of "LULD pause." Trading set to resume at 11:04 AM.
Eiger BioPharmaceuticals (Nasdaq:EIGR) Headline
Trading was temporarily halted for "EIGR" at 11:04 AM with a stated reason of "LULD pause."...
Eiger BioPharmaceuticals (Nasdaq:EIGR) Headline
Trading was temporarily halted for "EIGR" at 11:04 AM with a stated reason of "LULD pause."...
Eiger BioPharmaceuticals (Nasdaq:EIGR) Headline
Trading was temporarily halted for "EIGR" at 10:04 AM with a stated reason of "LULD pause."...
Eiger BioPharmaceuticals (Nasdaq:EIGR) Headline
Trading was temporarily halted for "EIGR" at 10:04 AM with a stated reason of "LULD pause." Trading set to resume at 10:04 AM.
Eiger BioPharmaceuticals (Nasdaq:EIGR) Headline
Trading was temporarily halted for "EIGR" at 10:04 AM with a stated reason of "LULD pause." Trading set to resume at 10:04 AM.
Eiger BioPharmaceuticals (Nasdaq:EIGR) Headline
Trading was temporarily halted for "EIGR" at 10:04 AM with a stated reason of "LULD pause."...
EIGR Eiger BioPharmaceuticals, Inc.
Eiger BioPharmaceuticals (Nasdaq:EIGR) Headline
Trading was temporarily halted for "EIGR" at 09:03 AM with a stated reason of "LULD pause."...
Eiger BioPharmaceuticals (Nasdaq:EIGR) Headline
Trading was temporarily halted for "EIGR" at 07:01 PM with a stated reason of "News pending."...
Why Is Eiger BioPharmaceuticals (EIGR) Stock Down 31% Today?
Eiger to discontinue hepatitis drug study
Eiger BioPharmaceuticals (Nasdaq:EIGR) Headline
Trading was temporarily halted for "EIGR" at 04:09 PM with a stated reason of "News pending."...
Citi Sticks to Their Buy Rating for Eiger Biopharmaceuticals (EIGR)
Get Eiger BioPharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for EIGR and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EIGR Media Mentions By Week

EIGR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

EIGR
News Sentiment

0.00

0.72

Average
Medical
News Sentiment

EIGR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

EIGR Articles
This Week

0

0

EIGR Articles
Average Week

Get the Latest News and Ratings for EIGR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Eiger BioPharmaceuticals and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:EIGR) was last updated on 9/6/2025 by MarketBeat.com Staff
From Our Partners